<unk> <unk>  syndrome is an autosomal dominant inherited disease, and having a family member with the disease places an individual at risk for the disease.  Family members of affected individuals should, therefore, be screened.  New-onset lone atrial fibrillation may be a marker of the disease, and young patients with lone atrial fibrillation should be screened as well.<unk> <unk>  syndrome should be excluded in patients without structural heart disease presenting with sudden cardiac death.
There is insufficient evidence to recommend routine screening for<unk> <unk>  syndrome. In the year 2011, The Heart Rhythm Society and the European Heart Rhythm Association have produced an expert consensus statement on genetic testing of channelopathies including SQTS. They recommend genetic testing to be conducted by a cardiologist who has a strong clinical suspicion of SQTS based on history, physical examination, family history, and electrocardiographic findings (grade IIb). Mutation-specific genetic testing is recommended for family members and appropriate relatives following the identification of the SQTS-causative mutation in an index case (grade I).New-onset lone atrial fibrillation may be a marker of the disease, and young patients with lone atrial fibrillation should be screened as well.<unk> <unk>  syndrome should be excluded in patients without structural heart disease presenting with sudden cardiac death.
Short QT syndrome screening
Left ventricular aneurysm screening
First degree AV block screening
Brugada syndrome screening
Third degree AV block screening
Hypertrophic cardiomyopathy screening
Dilated cardiomyopathy screening
Arrhythmogenic right ventricular dysplasia screening